152 related articles for article (PubMed ID: 34926665)
1. LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins.
Song Y; Du J; Lu P; Zou Q; Zeng S; Liu M; Hu X; Ma W; Lin H; Liu X; Niu F
Ann Transl Med; 2021 Nov; 9(21):1621. PubMed ID: 34926665
[TBL] [Abstract][Full Text] [Related]
2. Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.
Tong F; Xu L; Xu S; Zhang M
Front Genet; 2022; 13():834935. PubMed ID: 36105077
[No Abstract] [Full Text] [Related]
3. FAM83A antisense RNA 1 (
Zhao H; Wang Y; Wu X; Zeng X; Lin B; Hu S; Zhang S; Li Y; Zhou Z; Zhou Y; Du C; Beer DG; Bai S; Chen G
Bioengineered; 2022 May; 13(5):13312-13327. PubMed ID: 35635086
[TBL] [Abstract][Full Text] [Related]
4. The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action.
Pandini C; Pagani G; Tassinari M; Vitale E; Bezzecchi E; Saadeldin MK; Doldi V; Giannuzzi G; Mantovani R; Chiara M; Ciarrocchi A; Gandellini P
Cell Death Dis; 2024 Mar; 15(3):206. PubMed ID: 38467619
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
7. Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration.
Kou X; Zhu J; Xie X; Hao M; Zhao Y
Turk J Gastroenterol; 2020 Dec; 31(12):860-867. PubMed ID: 33625998
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
Guo JQ; Li SJ; Guo GX
Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Li YY; Li W; Chang GZ; Li YM
Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation.
Zhang H; Song J
Oncol Lett; 2021 Nov; 22(5):757. PubMed ID: 34539861
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
14. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
Gai SY; Yuan ZH
Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.
Wang J; Zha J; Wang X
Oncol Lett; 2021 Nov; 22(5):798. PubMed ID: 34630705
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
Hu Y; Zhao Z; Jin G; Guo J; Nan F; Hu X; Hu Y; Han Q
Bioengineered; 2022 Apr; 13(4):10749-10764. PubMed ID: 35475457
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA
Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
[No Abstract] [Full Text] [Related]
20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]